Bethany Leigh Fehsenfeld, RN, MSN, CNM | |
1474 Mno Bmadzewen Way, Fulton, MI 49052 | |
(269) 729-4422 | |
(269) 729-4460 |
Full Name | Bethany Leigh Fehsenfeld |
---|---|
Gender | Female |
Speciality | Advanced Practice Midwife |
Location | 1474 Mno Bmadzewen Way, Fulton, Michigan |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1427338839 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | 4704138929 (Michigan) | Primary |
Mailing Address | Practice Location Address |
---|---|
Bethany Leigh Fehsenfeld, RN, MSN, CNM 21335 County Road 653, Gobles, MI 49055-9242 Ph: (317) 694-5446 | Bethany Leigh Fehsenfeld, RN, MSN, CNM 1474 Mno Bmadzewen Way, Fulton, MI 49052 Ph: (269) 729-4422 |
News Archive
A Jackson County blood donor is the second person in Oregon to test positive for West Nile virus, according to public health and American Red Cross officials.
An international team of researchers has found that a once-a-month, high-dose injection of a commonly used asthma drug is highly effective in treating teens and adults chronically afflicted with hives and severe, itchy rash. The drug, omalizumab, was tested on 323 people at 55 medical centers for whom standard antihistamine therapy failed to quell their underlying, allergy-like reaction, known as chronic idiopathic urticaria or chronic spontaneous urticaria.
A play-based therapy aimed at helping parents manage children's behavior has seen long-lasting results in a live trial.
Eurofins MWG Operon and Geospiza, today announced that Eurofins MWG Operon has selected Geospiza's GeneSifter® Lab Edition software to manage its DNA sequencing systems and further enhance its market leading customer experience.
Exalenz Bioscience, a leader in developing and marketing non-invasive medical devices for diagnosing and monitoring a range of gastrointestinal and liver diseases, today announced the initiation of a clinical study designed to investigate its BreathID test to non-invasively detect primary liver cancer, also known as Hepatocellular Carcinoma (HCC).
› Verified 2 days ago